Enzon Pharmaceuticals Stock News

Enzon Pharmaceuticals Inc. (OTCMKTS:ENZN - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $0.10 and trade

CRANFORD, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has completed its previously announced exchange

CRANFORD, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that the previously approved 1-for-100 reverse stock sp

CRANFORD, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchang

CRANFORD, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchang

CRANFORD, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchang

CRANFORD, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchang

CRANFORD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expiration date for the exchange

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that it has commenced an exchange offer (the “Offer”

Enzon and Viskase stockholders will respectively own 45% and 55% of the combined company Enzon and Viskase stockholders will respectively own 45% and 55% of the combined company

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined company Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the com

You'll often hear people say that bear markets are great for finding bargains, and that's true. With the exception of energy, every major sector is in the red for the year.

Icosavax (NASDAQ:ICVX) and Enzon Pharmaceuticals (OTCMKTS:ENZN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for Icosavax and Enzon Pharmaceuticals, as reported []

Enzon Pharmaceuticals (OTCMKTS:ENZN) and Icosavax (NASDAQ:ICVX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Analyst Recommendations This is a summary of current ratings and price targets for Enzon Pharmaceuticals and [] The post Enzon Pharmaceuticals (OTCMKTS:ENZN) & Icosavax (NASDAQ:ICVX) Head-To-Head Contrast appeared first on ETF Daily News .

Enzon Pharmaceuticals (OTCMKTS: ENZN) is one of 232 public companies in the Biological products, except diagnostic industry, but how does it contrast to its competitors? We will compare Enzon Pharmaceuticals to related companies based on the strength of its dividends, institutional ownership, profitability, earnings, risk, valuation and analyst recommendations. Analyst Recommendations This is a summary []